Octagon Demands Board Hold July 30 Vote Without Delay, Urges Shareholders to Reject King Street Sub-Adviser
XFLT sits 23% above its 52-week low of $14.925.
Summary
Octagon's latest proxy filing demands the Board hold the July 30 special meeting without postponement and urges shareholders to vote against the King Street sub-adviser, arguing the proposal enriches XAI at shareholder expense and that a 'no' vote would force the Board to consider Octagon's alternative plan.
Key Events · Corporate Governance and Compliance · XFLT
-
Octagon Demands No Adjournment
Octagon calls on the Board to hold the July 30 special meeting without postponement or delay, and to refrain from adjourning without shareholder consent if the New Sub-Adviser Proposal lacks votes.
-
Conflict-of-Interest Allegation Sharpened
Octagon asserts the Board and XAI have never proposed a fee reduction or tender offer because those would reduce XAI's fee stream, while the New Sub-Adviser Proposal would increase XAI's share of management fees.
-
Mandate for Alternative Plan
Octagon urges a vote against the proposal to send a 'clear repudiation' of the Board and a mandate to engage on Octagon's plan for fee cuts, a tender offer, and board refreshment.
-
Proxy Contest Timeline
The special meeting is July 30, 2026; Octagon has filed multiple DFAN14A materials in recent weeks, and this press release is the final push before the vote.
Analysis · XFLT · Unknown
Three days before the special meeting, Octagon escalates the proxy fight by demanding the Board not adjourn or delay the vote, and by framing the New Sub-Adviser Proposal as a fee grab by XAI at shareholders' expense. Octagon explicitly calls for a mandate to force the Board to engage on its alternative plan—fee cuts, a tender offer, and board refreshment—if the proposal fails. This raises the stakes: a defeat would not just block King Street but could compel the Board to negotiate, while an adjournment would prolong uncertainty and dilute shareholder influence.
At the time of this filing, XFLT was trading at $18.35 on NYSE in the Unknown sector, with a market capitalization of approximately $267.6M. The 52-week trading range was $14.93 to $28.50. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.